LITTLE KNOWN FACTS ABOUT CONOLIDINE.

Our profiling and comparison in the steps of conolidine and cannabidiol with known pharmacological agents predicted a MOA shared with Cav2.2 channel blocker, ω-conotoxin CVIE.This kind of Examination has also been Utilized in the context of MEAs to a specific extent4,23. Therefore, we utilize dimensionality reduction methods to reduce the complexi